Abstract:Objective: To explore the effect of xylo-oligosaccharides on intestinal bacterial diversity in mice with spleen deficiency constipation. Methods: The 16S rDNA sequencing was used to identify microbiota composition in four groups, including the normal group (NG), the model group with spleen-deficiency constipation (SDC), XOS treated groups that include XOS1 groups treated XOS 0.05 g/mL•d, and XOS2 group treated XOS 0.1 g/mL•d. Chao1 and Shannon were used to conduct gut microbes diversity analysis. Linear discriminant analysis coupled with effect size measurements (LEfSe) was used to identify signature gut microbiota, and phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) was used to predict the function of altered gut microbiota. Results: Veen map indicated 245 common OTUs were identified from four groups. Especially, 9, 3, 0, and 19 unique OTUs were identified in NG, SDC, XOS1, and XOS2 groups, respectively. The Shannon index was evidently higher in NG group than in the other three groups ( p < 0.05). We identified the occurrence of dominant bacterial groups including Bacteroidetes (25.5 ~ 49.9%), Firmicutes (25.4 ~ 39.3%), Proteobacteria (12.5 ~ 24.9%), Deferribacteres (1.6 ~ 19.2%), Cyanobacteria (0.3 ~ 1.8%), Verrucomicrobia (0.02 ~ 1.6%), Actinobacteria (0.01 ~ 0.5%), and Tenericutes (0.03 ~ 0.09%) at the four groups. The XOS2 group was characterized by a higher abundance of Peptostreptococcaceae , Intestinibacter , Aerococcaceae , and Facklamia . XOS1 group enriched in Deferribacteres , Mucispirillum , Deferribacterales , Deferribacteres , Lachnoclostridium , Rhodospirillaceae , and Rhodospirillales . Meanwhile, the SDC mice showed dramatic enrichment in Rikenellaceae , Lachnospiraceae , Rikenellaceae , Roseburia , and Alistipes , which were highly abundant in the NG group. XOS fed-mice evidently increase Deferribcteres abundance compared with NG and SDC groups. However, the abundance of Rikenellaceae was significantly reduced in XOS1 and XOS2 groups compared with NG and SDC groups. We identified that altered gut microbiotas by XOS treatment were associated with various metabolic pathways, including organismal systems, metabolism, human diseases, genetic information processing, and cellular processes. Conclusion: Our research indicated that XOS has the potential to recover intestinal bacteria and contribute to the treatment of spleen deficiency constipation.

Xylooligosaccharides Increase Bifidobacteria and Lachnospiraceae in Mice on a High-Fat Diet, with a Concomitant Increase in Short-Chain Fatty Acids, Especially Butyric Acid

Prebiotic Oligosaccharides Change the Concentrations of Short-Chain Fatty Acids and the Microbial Population of Mouse Bowel.

Effects of Xylooligosaccharides on Lipid Metabolism, Inflammation, and Gut Microbiota in C57BL/6J Mice Fed a High-Fat Diet

Effects of a Galacto-Oligosaccharide-rich Diet on Fecal Microbiota and Metabolite Profiles in Mice.

Effect of xylo-oligosaccharides on intestinal bacterial diversity in mice with spleen deficiency constipation

Dose-dependent effects of xylooligosaccharides on glycemic regulation with L. rhamnosus CCFM1060 in diabetic mice

Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats

The High Level of Xylooligosaccharides Improves Growth Performance in Weaned Piglets by Increasing Antioxidant Activity, Enhancing Immune Function, and Modulating Gut Microbiota.

Metagenomic Insights into the Effects of Fructooligosaccharides (FOS) on the Composition of Luminal and Mucosal Microbiota in C57BL/6J Mice, Especially the Bifidobacterium Composition

Xylooligosaccharides (XOS) Ameliorate Insulin Resistance by Increasing Akkermansia Muciniphila and Improving Intestinal Barrier Dysfunction in Gestational Diabetes Mellitus (GDM) Mice

Xylooligosaccharides Ameliorate Insulin Resistance by Increasing Akkermansia Muciniphila and Improving Intestinal Barrier Dysfunction in Gestational Diabetes Mellitus Mice.

Effect of Dietary Xylooligosaccharides on Intestinal Characteristics, Gut Microbiota, Cecal Short-Chain Fatty Acids, and Plasma Immune Parameters of Laying Hens.

Metagenomic Insights into the Effects of Fructo-Oligosaccharides (FOS) on the Composition of Fecal Microbiota in Mice.

Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice

Regulatory Effects of Xylooligosaccharides on Intestinal Microbial Flora Proliferation and Defecation of BALB/c Mice

Cooperative action of non-digestible oligosaccharides improves lipid metabolism of high-fat diet-induced mice

Xyloglucan Compounded Inulin or Arabinoxylan Against Glycometabolism Disorder Via Different Metabolic Pathways: Gut Microbiota and Bile Acid Receptor Effects

Effects of xylo-oligosaccharide on growth performance, serum biochemical,immune indexes and fecal bacterial community in fattening pigs

Arabinoxylan-oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the Simulator of Human Intestinal Microbial Ecosystem

Effects of Dietary Fiber Supplementation on Fatty Acid Metabolism and Intestinal Microbiota Diversity in C57BL/6J Mice Fed with a High-Fat Diet

Xanthan Gum Oligosaccharides Ameliorate Glucose Metabolism and Related Gut Microbiota Dysbiosis in Type 2 Diabetic Mice